Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $556,963 | 169 | 50.9% |
| Travel and Lodging | $173,469 | 292 | 15.8% |
| Consulting Fee | $132,805 | 42 | 12.1% |
| Honoraria | $102,500 | 44 | 9.4% |
| Unspecified | $71,912 | 6 | 6.6% |
| Food and Beverage | $31,939 | 939 | 2.9% |
| Education | $24,895 | 8 | 2.3% |
| Entertainment | $26.38 | 1 | 0.0% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Boston Scientific Corporation | $730,596 | 750 | $0 (2024) |
| GRT US Holding, Inc. | $99,669 | 136 | $0 (2022) |
| Averitas Pharma Inc. | $97,957 | 161 | $0 (2024) |
| Eli Lilly and Company | $53,602 | 2 | $0 (2024) |
| Spinal Simplicity, LLC | $40,979 | 71 | $0 (2024) |
| Depomed, Inc. | $40,788 | 59 | $0 (2017) |
| US WorldMeds, LLC | $18,355 | 8 | $0 (2020) |
| EAGLE PHARMACEUTICALS, INC. | $3,644 | 4 | $0 (2024) |
| Vertos Medical, Inc. | $1,824 | 2 | $0 (2024) |
| ACACIA PHARMA INC | $1,022 | 3 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $225,754 | 243 | Boston Scientific Corporation ($106,912) |
| 2023 | $145,789 | 280 | Boston Scientific Corporation ($69,310) |
| 2022 | $174,641 | 319 | GRT US Holding, Inc. ($99,669) |
| 2021 | $46,526 | 93 | BOSTON SCIENTIFIC CORPORATION ($45,881) |
| 2020 | $38,643 | 28 | Boston Scientific Corporation ($38,467) |
| 2019 | $101,252 | 111 | Boston Scientific Corporation ($82,265) |
| 2018 | $207,778 | 188 | BOSTON SCIENTIFIC CORPORATION ($205,160) |
| 2017 | $154,127 | 239 | BOSTON SCIENTIFIC CORPORATION ($112,467) |
All Payment Transactions
1,501 individual payment records from CMS Open Payments — Page 1 of 61
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Boston Scientific Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,950.00 | General |
| Category: General - Therapies_NMD | ||||||
| 12/27/2024 | Boston Scientific Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,400.00 | General |
| Category: General - Therapies_NMD | ||||||
| 12/27/2024 | Boston Scientific Corporation | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,100.00 | General |
| Category: General - Therapies_NMD | ||||||
| 12/26/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $9.21 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/19/2024 | Boston Scientific Corporation | Precision (Device) | Consulting Fee | Cash or cash equivalent | $8,800.00 | General |
| Category: Precision_NMD | ||||||
| 12/19/2024 | Boston Scientific Corporation | Precision (Device) | Consulting Fee | Cash or cash equivalent | $1,100.00 | General |
| Category: Precision_NMD | ||||||
| 12/19/2024 | Boston Scientific Corporation | Precision (Device) | Travel and Lodging | Cash or cash equivalent | $569.95 | General |
| Category: Precision_NMD | ||||||
| 12/19/2024 | Boston Scientific Corporation | Precision (Device) | Travel and Lodging | Cash or cash equivalent | $300.68 | General |
| Category: Precision_NMD | ||||||
| 12/19/2024 | Boston Scientific Corporation | Precision (Device) | Food and Beverage | Cash or cash equivalent | $79.64 | General |
| Category: Precision_NMD | ||||||
| 12/19/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $39.74 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 12/19/2024 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $4.28 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/17/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 12/11/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Honoraria | Cash or cash equivalent | $2,400.00 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/11/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $750.00 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/11/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Travel and Lodging | Cash or cash equivalent | $133.33 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/11/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: NEUROSCIENCE | ||||||
| 12/09/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Honoraria | Cash or cash equivalent | $2,400.00 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/09/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $1,250.00 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/09/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Travel and Lodging | Cash or cash equivalent | $419.42 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/09/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Travel and Lodging | Cash or cash equivalent | $224.45 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/09/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Travel and Lodging | Cash or cash equivalent | $52.86 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/08/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $148.56 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 12/07/2024 | Boston Scientific Corporation | WaveWriter Alpha Prime 16 (Device) | Food and Beverage | In-kind items and services | $37.03 | General |
| Category: WaveWriter Alpha_NMD | ||||||
| 12/05/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $153.90 | General |
| Category: PAIN MANAGEMENT | ||||||
| 12/05/2024 | Averitas Pharma Inc. | QUTENZA (Drug) | Food and Beverage | In-kind items and services | $10.27 | General |
| Category: PAIN MANAGEMENT | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, DOSE-FINDING STUDY EVALUATING LY3848575 IN CHRONIC NEUROPATHIC PAIN ASSOCIATED WITH DISTAL SENSORY POLYNEUROPATHY | Eli Lilly and Company | $53,602 | 2 |
| Lofexidine Clinical Adult Taper Study | US WorldMeds, LLC | $18,310 | 4 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 36 | 2,302 | 5,547 | $2.0M | $481,306 |
| 2022 | 43 | 2,306 | 5,336 | $1.6M | $414,884 |
| 2021 | 55 | 3,578 | 6,769 | $2.1M | $547,187 |
| 2020 | 31 | 1,711 | 3,126 | $847,799 | $186,232 |
All Medicare Procedures & Services
167 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 515 | 1,801 | $270,200 | $151,837 | 56.2% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 339 | 477 | $131,150 | $72,799 | 55.5% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 353 | 500 | $75,000 | $29,605 | 39.5% |
| 63650 | Insertion of spinal neurostimulator electrode array through skin | Office | 2023 | 11 | 22 | $112,200 | $28,209 | 25.1% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 49 | 56 | $224,700 | $26,269 | 11.7% |
| 64483 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level | Office | 2023 | 48 | 79 | $85,800 | $18,336 | 21.4% |
| 63650 | Insertion of spinal neurostimulator electrode array through skin | Facility | 2023 | 32 | 66 | $336,600 | $15,351 | 4.6% |
| 64636 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 49 | 59 | $86,400 | $14,655 | 17.0% |
| 64493 | Injection of lower or sacral spine facet joint using imaging guidance, single level | Office | 2023 | 48 | 69 | $93,100 | $12,782 | 13.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 86 | 86 | $17,200 | $10,666 | 62.0% |
| 27096 | Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance | Office | 2023 | 40 | 56 | $73,600 | $8,458 | 11.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 116 | 144 | $14,390 | $7,820 | 54.3% |
| 64633 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint | Office | 2023 | 19 | 19 | $62,000 | $7,777 | 12.5% |
| 63685 | Insertion of spinal neurostimulator generator or receiver | Facility | 2023 | 43 | 44 | $88,000 | $6,961 | 7.9% |
| J7999 | Compounded drug, not otherwise classified | Office | 2023 | 21 | 64 | $10,398 | $6,408 | 61.6% |
| 64494 | Injection of lower or sacral spine facet joint using imaging guidance, second level | Office | 2023 | 46 | 67 | $54,975 | $6,396 | 11.6% |
| 64640 | Destruction of peripheral nerve or branch | Office | 2023 | 21 | 30 | $30,900 | $6,293 | 20.4% |
| 64624 | Destruction of nerve branches of knee using imaging guidance | Office | 2023 | 12 | 16 | $11,900 | $4,625 | 38.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 30 | 30 | $7,950 | $4,592 | 57.8% |
| 64555 | Insertion of peripheral nerve neurostimulator electrode through skin | Facility | 2023 | 12 | 24 | $48,000 | $4,368 | 9.1% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2023 | 18 | 18 | $27,000 | $4,317 | 16.0% |
| 62370 | Electronic analysis reprogramming and refill of spinal canal drug infusion pump by physician | Office | 2023 | 25 | 74 | $44,400 | $4,307 | 9.7% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2023 | 24 | 37 | $22,040 | $3,976 | 18.0% |
| 64454 | Injection of anesthetic agent and/or steroid into knee nerve branch using imaging guidance | Office | 2023 | 11 | 22 | $10,000 | $3,848 | 38.5% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2023 | 13 | 21 | $24,500 | $3,788 | 15.5% |
About Dr. James North, MD
Dr. James North, MD is a Pain Medicine healthcare provider based in Winston Salem, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780638163.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. James North, MD has received a total of $1.1M in payments from pharmaceutical and medical device companies, with $225,754 received in 2024. These payments were reported across 1,501 transactions from 54 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($556,963).
As a Medicare-enrolled provider, North has provided services to 9,897 Medicare beneficiaries, totaling 20,778 services with total Medicare billing of $1.6M. Data is available for 4 years (2020–2023), covering 167 distinct procedure/service records.
Practice Information
- Specialty Pain Medicine
- Location Winston Salem, NC
- Active Since 05/20/2006
- Last Updated 09/09/2020
- Taxonomy Code 208VP0000X
- Entity Type Individual
- NPI Number 1780638163
Products in Payments
- SPECTRA WAVEWRITER (Device) $224,756
- Qutenza (Drug) $99,669
- QUTENZA (Drug) $97,957
- PRECISION (Device) $67,475
- Precision (Device) $65,480
- WaveWriter Alpha Prime 16 (Device) $48,696
- GENERAL PAIN MANAGEMENT (Device) $45,832
- GENERAL - PAIN MANAGEMENT (Device) $41,301
- Nucynta (Drug) $40,788
- HA MINUTEMAN G3-R (Device) $39,540
- General - Therapies (Device) $28,831
- WAVEWRITER ALPHA (Device) $21,999
- SPECTRA (Device) $20,443
- THERAPIES (Device) $19,561
- Lucemyra/Lofexidine (Drug) $18,262
- SPECTRA WAVEWRITER (REFURBISHED) (Device) $11,874
- Superion Indirect Decompression System (Device) $11,867
- INFINION (Device) $9,801
- FIXATE (Device) $8,944
- BYFAVO (Drug) $4,666
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pain Medicine Doctors in Winston Salem
Leonardo Kapural, M.d, M.D
Pain Medicine — Payments: $1.1M
Dr. Christopher Gilmore, Md, MD
Pain Medicine — Payments: $548,646
Daniel Bintrim, M.d, M.D
Pain Medicine — Payments: $36,124
Dr. Paul Harkins, Md, MD
Pain Medicine — Payments: $22,233
Chuanyao Tong, Md, MD
Pain Medicine — Payments: $20,759
Peter Pan, Md, MD
Pain Medicine — Payments: $14,992